Imagenebio Inc (IMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,219 | -68,765 | -54,668 | -37,330 | -16,839 |
| Depreciation Amortization | -299 | 801 | 644 | 397 | 222 |
| Accounts payable and accrued liabilities | 666 | -291 | -206 | 952 | 4 |
| Other Working Capital | -7,603 | -15,138 | -9,234 | -6,958 | -5,379 |
| Other Operating Activity | 1,671 | 9,284 | 7,010 | 3,704 | 2,208 |
| Operating Cash Flow | $-19,784 | $-74,109 | $-56,454 | $-39,235 | $-19,784 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -152 | -1,431 | -1,200 | -69 | -33 |
| Purchase Of Investment | -41,726 | -216,338 | -189,863 | -174,996 | -166,018 |
| Sale Of Investment | 31,072 | 118,485 | 81,280 | 29,500 | 0 |
| Investing Cash Flow | $-10,806 | $-99,284 | $-109,783 | $-145,565 | $-166,051 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,095 | 1,094 | 1,070 | 495 |
| Financing Cash Flow | $N/A | $1,095 | $1,094 | $1,070 | $495 |
| Beginning Cash Position | 60,791 | 233,089 | 233,089 | 233,089 | 233,089 |
| End Cash Position | 30,201 | 60,791 | 67,946 | 49,359 | 47,749 |
| Net Cash Flow | $-30,590 | $-172,298 | $-165,143 | $-183,730 | $-185,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,784 | -74,109 | -56,454 | -39,235 | -19,784 |
| Capital Expenditure | -152 | -1,431 | -1,200 | -69 | -33 |
| Free Cash Flow | -19,936 | -75,540 | -57,654 | -39,304 | -19,817 |